1 – 10 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Time between milestone events in the Alzheimer's disease amyloid cascade (
- 2020
- An Epigenetic Approach to Semantic Categories (
- Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease (
- A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia (
- Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study : CSF/s-T4 associated with QoL in hypothyroidism (
- Cerebro-spinal fluid biomarker levels : phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease (
- Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease (
- Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease (
- The type and timing of patent ductus arteriosus treatment was associated with neurodevelopment when extremely preterm infants reached 6.5 years (
- Tau PET and relative cerebral blood flow in dementia with Lewy bodies : A PET study (